James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 3,182 shares at $46.78 ($149K) on 2026-03-23, disclosed to the SEC on 2026-03-24.
Seasonal sale ($149k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |